Variant report
Variant | nsv1004528 |
---|---|
Chromosome Location | chr2:57078722-57182354 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:57125151..57127960-chr2:57127962..57130049,3 | K562 | blood: | |
2 | chr2:57125151..57127960-chr2:57127962..57130049,3 | K562 | blood: | |
3 | chr2:57078712..57081570-chr2:57085174..57087217,2 | MCF-7 | breast: | |
4 | chr2:57035108..57036803-chr2:57124744..57126282,2 | K562 | blood: | |
5 | chr2:57078712..57081570-chr2:57085174..57087217,2 | MCF-7 | breast: | |
6 | chr2:57140755..57141275-chr7:78397919..78398439,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs538302692 | chr2:57078746-57078747 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs141208081 | chr2:57078761-57078762 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs115080728 | chr2:57078822-57078823 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs536619123 | chr2:57078847-57078848 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs556260279 | chr2:57078850-57078851 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs576513561 | chr2:57078858-57078859 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs193180449 | chr2:57078859-57078860 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs370856977 | chr2:57078883-57078884 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs12616913 | chr2:57078884-57078885 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
10 | rs368672966 | chr2:57078931-57078932 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs571865202 | chr2:57078945-57078946 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs146942807 | chr2:57079001-57079002 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs12623476 | chr2:57079067-57079068 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs574118783 | chr2:57079068-57079069 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs115090465 | chr2:57079125-57079126 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs541107266 | chr2:57079135-57079136 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs567864122 | chr2:57079146-57079147 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs550159186 | chr2:57079841-57079842 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
19 | rs115765368 | chr2:57079906-57079907 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
20 | rs538906798 | chr2:57079938-57079939 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
21 | rs553352196 | chr2:57079961-57079962 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
22 | rs552277830 | chr2:57079991-57079992 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
23 | rs565866928 | chr2:57079998-57079999 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
24 | rs534778910 | chr2:57080018-57080019 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs554384553 | chr2:57080019-57080020 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs201047809 | chr2:57080056-57080057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs374981683 | chr2:57080091-57080092 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs189929534 | chr2:57080174-57080175 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs556941309 | chr2:57080186-57080187 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs13385244 | chr2:57080208-57080209 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs576793456 | chr2:57080244-57080245 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs545841785 | chr2:57080254-57080255 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs552987419 | chr2:57080303-57080304 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs141763256 | chr2:57080307-57080308 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs541941810 | chr2:57080314-57080315 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs10167375 | chr2:57080338-57080339 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs565908695 | chr2:57080348-57080349 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs565393060 | chr2:57080407-57080408 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs116589225 | chr2:57080570-57080571 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs36125200 | chr2:57080613-57080614 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs532820772 | chr2:57080627-57080628 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs554755553 | chr2:57080630-57080631 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs552190026 | chr2:57080633-57080634 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs181730291 | chr2:57080690-57080691 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs528609921 | chr2:57080692-57080693 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs548231341 | chr2:57080698-57080699 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs57783089 | chr2:57080715-57080716 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs535956454 | chr2:57080717-57080718 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs554313015 | chr2:57080743-57080744 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs570688689 | chr2:57080749-57080750 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Mental retardation | 19951919 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Microcephaly | 20799320 | CNVD |
camptodactyly | 20799320 | CNVD |
cognitive delay | 20799320 | CNVD |
prenatal and postnatal growth deficiency | 20799320 | CNVD |
ptosis of eyelids | 20799320 | CNVD |
Maculopathy | 20981449 | CNVD |
2p16.1 microdeletion syndrome | 22283845 | CNVD |
Autism | 22579565 | CNVD |
Autism | 16963482 | CNVD |
Autism | 21750575 | CNVD |
idiopathic intellectual disability | 16963482 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:57078600-57079200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr2:57079800-57080000 | ZNF genes & repeats | Primary T helper naive cells from peripheral blood | blood |
3 | chr2:57080000-57081400 | Weak transcription | Primary T helper naive cells from peripheral blood | blood |
4 | chr2:57098200-57098600 | Enhancers | NHEK | skin |
5 | chr2:57101000-57104200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr2:57102000-57102800 | Enhancers | Spleen | Spleen |
7 | chr2:57132800-57133200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
8 | chr2:57132800-57133200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
9 | chr2:57145800-57146200 | Enhancers | Aorta | Aorta |
10 | chr2:57161600-57162600 | Enhancers | Fetal Brain Female | brain |
11 | chr2:57162400-57162600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
12 | chr2:57164400-57165000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
13 | chr2:57164400-57165000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
14 | chr2:57164400-57165000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
15 | chr2:57165600-57166000 | Enhancers | Fetal Brain Male | brain |
16 | chr2:57166800-57167000 | Enhancers | HUES64 Cell Line | embryonic stem cell |